Zhejiang Jiuzhou Pharm Co Ltd
Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecule, drug product, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and … Read more
Zhejiang Jiuzhou Pharm Co Ltd (603456) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: 0.032x
Based on the latest financial reports, Zhejiang Jiuzhou Pharm Co Ltd (603456) has a cash flow conversion efficiency ratio of 0.032x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥261.98 Million) by net assets (CN¥8.11 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Jiuzhou Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Zhejiang Jiuzhou Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Jiuzhou Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Jiuzhou Pharm Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Carel Industries S.p.A.
LSE:0YQA
|
0.078x |
|
Beijing Qianjing Landscape Co
SHG:603778
|
0.167x |
|
SYLVAMO CORP. DL 100
F:88L
|
N/A |
|
Everi Holdings Inc
NYSE:EVRI
|
1.295x |
|
Willdan Group Inc
NASDAQ:WLDN
|
0.043x |
|
The South Indian Bank Limited
NSE:SOUTHBANK
|
0.246x |
|
NPK International Inc.
NYSE:NPKI
|
0.054x |
|
Evotec SE
PINK:EVOTF
|
-0.084x |
Annual Cash Flow Conversion Efficiency for Zhejiang Jiuzhou Pharm Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Jiuzhou Pharm Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥8.61 Billion | CN¥991.66 Million | 0.115x | -27.75% |
| 2023-12-31 | CN¥8.53 Billion | CN¥1.36 Billion | 0.159x | -30.14% |
| 2022-12-31 | CN¥5.37 Billion | CN¥1.23 Billion | 0.228x | +54.17% |
| 2021-12-31 | CN¥4.58 Billion | CN¥677.52 Million | 0.148x | +14.09% |
| 2020-12-31 | CN¥3.09 Billion | CN¥400.39 Million | 0.130x | -33.08% |
| 2019-12-31 | CN¥2.86 Billion | CN¥554.16 Million | 0.194x | +103.41% |
| 2018-12-31 | CN¥2.78 Billion | CN¥264.78 Million | 0.095x | -6.98% |
| 2017-12-31 | CN¥2.68 Billion | CN¥274.68 Million | 0.102x | +92.47% |
| 2016-12-31 | CN¥2.57 Billion | CN¥136.65 Million | 0.053x | -4.69% |
| 2015-12-31 | CN¥2.52 Billion | CN¥140.53 Million | 0.056x | +769.76% |
| 2014-12-31 | CN¥1.58 Billion | CN¥10.17 Million | 0.006x | -97.68% |
| 2013-12-31 | CN¥736.75 Million | CN¥203.86 Million | 0.277x | +7.08% |
| 2012-12-31 | CN¥597.08 Million | CN¥154.28 Million | 0.258x | +7.20% |
| 2011-12-31 | CN¥460.54 Million | CN¥111.01 Million | 0.241x | -- |